“Pulmonary” refers to anything involving the lungs, from the way oxygen crosses into your blood to the diseases that interfere with that process. Your lungs are not passive bags that fill and empty; they are a complex organ system with their own dedicated blood supply, a built-in chemical defense layer, an intricate control network, and an ability to redirect blood flow on the fly. Understanding how this system works, and where it breaks down, helps make sense of conditions ranging from asthma and COPD to pulmonary embolism and acute respiratory distress.
How Gas Exchange Actually Works
The basic job of the lungs is to get oxygen into the blood and carbon dioxide out. This happens across the walls of about 300 million tiny air sacs called alveoli, which together create a surface area roughly the size of a tennis court. But keeping those sacs open is harder than it sounds. The thin film of fluid lining each alveolus creates surface tension that would, without intervention, cause the sac to collapse like a wet plastic bag sticking to itself.
That intervention is pulmonary surfactant, a mixture of fats and proteins produced by specialized cells in the alveolar lining. Surfactant is essential for life: it lowers surface tension at the air-liquid interface, preventing the alveoli from collapsing during exhalation.1PubMed Central. The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections During each breath out, the alveolar surface area shrinks. As that happens, the surfactant film compresses and drives surface tension down to extremely low values, keeping the sac from snapping shut.2PubMed Central. The biophysical function of pulmonary surfactant The result is that alveoli stay partially inflated between breaths, which means your next inhalation does not have to start from scratch.
Premature infants often lack adequate surfactant, which is why respiratory distress syndrome is so dangerous in newborns. Synthetic and animal-derived surfactant replacement therapy transformed neonatal care decades ago, and researchers continue to study the precise way surfactant molecules organize themselves at the air-water boundary. One line of research has modeled how certain lipid components get squeezed out of the film during compression, leaving behind a tightly packed layer that can push surface tension to near zero.3PubMed Central. On the Low Surface Tension of Lung Surfactant
The Pulmonary Circulation Is Not Like the Rest of Your Circulatory System
Most people think of blood circulation as one loop: heart pumps blood, blood goes around the body, blood returns. In reality there are two loops, and the pulmonary circuit is the smaller, lower-pressure one. The right side of the heart sends oxygen-depleted blood through the pulmonary arteries to the lungs, where it picks up oxygen and dumps carbon dioxide, then returns to the left side of the heart to be pumped out to everything else. Because the lungs are right next to the heart and do not need high pressure to be perfused, pulmonary artery pressure runs much lower than systemic blood pressure.
One of the most elegant features of this circuit is hypoxic pulmonary vasoconstriction, or HPV. If a region of the lung is not getting enough air, maybe because a small airway is partially blocked, the blood vessels serving that region automatically constrict. This redirects blood toward better-ventilated areas, matching blood flow to air flow and making gas exchange more efficient.4PubMed Central. Hypoxic Pulmonary Vasoconstriction: An Important Component of the Homeostatic Oxygen Sensing System Computational modeling has shown that this mechanism can meaningfully increase total oxygen uptake across an entire lobe.5PubMed Central. Hypoxic pulmonary vasoconstriction as a regulator of alveolar-capillary oxygen flux: A computational model of ventilation-perfusion matching It is a local, automatic response that requires no conscious input and no signal from the brain.
When this system goes wrong on a large scale, the consequences are serious. Pulmonary arterial hypertension, or PAH, involves progressive remodeling of the small blood vessels in the lungs. The vessel walls thicken, the channels narrow, and pulmonary artery pressure climbs. The right side of the heart has to work much harder to push blood through, and over time it can fail. A central driver of this process is dysfunction of the endothelial cells lining the pulmonary arteries, which can tip into abnormal proliferation, inflammation, and even a transformation where they start behaving like muscle-like cells.6PubMed Central. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series) Research on patients with a specific form of PAH linked to autoimmune disease found these transformed cells in up to five percent of pulmonary vessels, and laboratory studies have shown that once this transformation occurs, the affected cells leak, promote inflammation, and attract immune cells rather than forming a proper barrier.7PubMed. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
What Controls Your Breathing
You rarely think about breathing, yet you take somewhere around 20,000 breaths a day. The rhythm is set by groups of neurons in the brainstem, but the pace and depth are constantly adjusted by chemical sensors. The most powerful driver of breathing rate is carbon dioxide. Even a small rise in blood COâ‚‚ triggers a large increase in breathing, and a dip below normal levels can slow breathing to the point of temporary pauses, especially during sleep or under anesthesia.8PubMed. CO2, brainstem chemoreceptors and breathing
Oxygen monitoring also matters, but it works differently. Specialized structures called the carotid bodies, located at the branching points of the carotid arteries in the neck, detect falling oxygen levels and fire urgent signals to the brain. Under normal circumstances, they provide a steady background input to the breathing centers. When oxygen drops sharply, such as at high altitude or during a choking event, they ramp up dramatically. Meanwhile, the brainstem’s own central sensors primarily track COâ‚‚ levels in the surrounding fluid.9PubMed. The chemoreflex control of breathing and its measurement The interplay between these systems explains why, for instance, hyperventilating before a dive can be dangerous: you blow off enough COâ‚‚ to suppress your drive to breathe, but oxygen levels may still be falling.
Obstructive Versus Restrictive Lung Disease
When clinicians talk about pulmonary disease, they usually start by dividing conditions into two broad families. Obstructive diseases make it hard to push air out. Restrictive diseases make it hard to get air in, because the lungs cannot expand fully. The distinction matters because the underlying problems, the treatments, and the outlook are different.
Asthma and chronic obstructive pulmonary disease (COPD) are the headline obstructive conditions. Both involve airway inflammation and remodeling, but the patterns differ in important ways. In asthma, the airway lining tends to be fragile, the membrane just beneath it thickens substantially, and the smooth muscle around the airways enlarges. In COPD, the changes lean toward excess mucus production, scarring (fibrosis) of the airway walls, and, critically, destruction of the alveolar walls themselves, which is what produces emphysema.10PubMed. Remodeling in asthma and chronic obstructive lung disease Even the immune cells involved differ: asthma tends to recruit eosinophils and mast cells, while COPD draws in macrophages and a different subset of immune lymphocytes.11PubMed. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease In severe cases of either disease, though, the picture can blur, and some patients have features of both.
On the restrictive side, idiopathic pulmonary fibrosis (IPF) is one of the most devastating examples. In IPF, clusters of overactive fibroblasts (cells that produce connective tissue) appear in the lung’s air spaces and start laying down collagen at an abnormal rate.12European Respiratory Review. Matrix abnormalities in pulmonary fibrosis These clusters, called fibroblastic foci, are hallmarks of the disease and represent sites of active scarring. Within them, the fibroblasts take on properties of muscle cells, producing both collagen and the structural protein that lets muscles contract.13PubMed Central. The roles of the myofibroblast in idiopathic pulmonary fibrosis The result is progressively stiffened lung tissue that cannot inflate properly, gradually robbing the patient of breathing capacity.
Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a severe, rapid-onset form of lung failure that can develop after pneumonia, sepsis, major trauma, or even a severe viral infection. The earliest visible problem is protein-rich fluid flooding the alveoli, which is a sign that the barrier between the blood and the air spaces has broken down.14PubMed Central. New insights into the mechanisms of pulmonary edema in acute lung injury
Normally, the pulmonary capillaries have walls thin enough to allow gas exchange but tight enough to keep fluid where it belongs. In ARDS, a cascade of inflammation, immune-cell infiltration, and direct cell damage opens gaps in both the capillary walls and the alveolar lining. Fluid seeps first into the space between cells and then into the alveoli themselves. The lungs can initially absorb a surprising amount of extra fluid: the interstitial space can swell by as much as forty percent before overt pulmonary edema develops. Once that buffer is overwhelmed, though, the alveoli flood and gas exchange collapses.15PubMed Central. The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches
Treatment centers on supporting the patient while the lungs heal. Mechanical ventilation is nearly always necessary, but the ventilator itself can cause further damage if pressures or volumes are too high. In the most severe cases, where even careful mechanical ventilation cannot maintain adequate oxygen levels, clinicians turn to extracorporeal membrane oxygenation (ECMO). In veno-venous ECMO, blood is drawn from a large vein, run through an external device that adds oxygen and removes carbon dioxide, and returned to the patient. This lets the ventilator settings be dialed way down, giving the lungs a chance to rest. An international survey of ECMO centers found that the overwhelming majority, about ninety-three percent, considered lung rest the primary goal of ventilation during ECMO support, using very low tidal volumes, slow breathing rates, and gentle pressures.16PubMed Central. International Survey on Mechanical Ventilation During Extracorporeal Membrane Oxygenation Optimizing the gas exchange on the ECMO circuit itself involves balancing blood flow rates, the oxygen content of the sweep gas, and the patient’s own remaining lung function.17PubMed Central. Optimizing Extracorporeal Membrane Oxygenation Gas Exchange: Key Insights for Clinical Management
Pulmonary Embolism and the Threat From Elsewhere
Not all pulmonary emergencies originate in the lungs. A pulmonary embolism happens when a blood clot, usually formed in the deep veins of the legs, breaks free and travels through the bloodstream until it lodges in a pulmonary artery. The blockage raises pressure in the pulmonary circuit and forces the right ventricle to strain against the obstruction. In serious cases, the right ventricle can dilate and weaken, reducing the heart’s overall output and potentially leading to chronic pulmonary hypertension if the clot is not fully resolved.18PubMed Central. Pulmonary Embolism and Right Ventricular Dysfunction: Mechanism and Management The severity depends largely on the size and number of clots and on how healthy the heart was before the event. Small emboli may cause nothing more than mild breathlessness, while a large saddle embolus straddling the main pulmonary artery can be immediately life-threatening.
Air Pollution and the Lungs
The lungs are the organ most directly exposed to whatever is in the air, and fine particulate matter (PM2.5, particles smaller than 2.5 micrometers) is among the most studied environmental threats. These particles are small enough to reach the deepest parts of the lung and deposit on the alveolar surface. Once there, they are taken up primarily by alveolar macrophages, the resident immune cells whose job is to engulf and remove foreign material. Together with the epithelial cells lining the airways, macrophages produce inflammatory signals in response to inhaled particles.19PubMed Central. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants Research on human immune cells exposed to PM2.5 has shown that the particles reduce cell survival and ramp up production of inflammatory molecules by activating a key family of genes involved in the immune response.20PubMed Central. Effects of Different Components of PM2.5 on the Expression Levels of NF-κB Family Gene mRNA and Inflammatory Molecules in Human Macrophage This chronic, low-grade inflammation is thought to be one pathway through which long-term air pollution exposure contributes to conditions like COPD, lung cancer, and cardiovascular disease.
Mucociliary Clearance and the Lung’s Built-In Defense
Before anything reaches the alveoli, the airways have a self-cleaning system. Goblet cells in the airway lining secrete mucus, which traps inhaled particles, bacteria, and viruses. Tiny hair-like projections called cilia beat in coordinated waves, sweeping the mucus up toward the throat, where it is swallowed or coughed out. This mucociliary escalator is one of the body’s most important front-line defenses.
Cystic fibrosis shows what happens when this system fails. In CF, a defective ion channel causes the airway surface liquid to become dehydrated, producing thick, sticky mucus that the cilia cannot move efficiently. The result is a failure to sustain healthy transport of mucus out of the airways, leading to chronic bacterial infections and progressive lung damage.21PubMed Central. Mucociliary transport in cystic fibrosis Research using advanced imaging in newborn CF pigs has confirmed that clearance is impaired even in the smallest airways from birth, with CF animals clearing roughly fifteen percent of delivered test particles compared to about twenty-five percent in healthy controls.22PubMed Central. Mucociliary clearance is impaired in small airways of cystic fibrosis pigs The discovery that the defect begins in the smallest airways has shifted attention toward therapies that can reach those deep branches early in life.
How the Lungs Change With Age
Even in perfectly healthy people, the lungs gradually change over the decades. The elastic fibers surrounding the alveoli degenerate in a slow, uniform way, causing the air spaces to widen without the kind of wall destruction seen in emphysema. This process, sometimes called senile emphysema despite being histologically distinct from true emphysema, results in a small but steady decline in the lung’s elastic recoil, roughly 0.1 to 0.2 cmHâ‚‚O per year.23Ann Cardiopulm Rehabil. Understanding Changes in the Respiratory System with Ageing The smallest airways, those under about two millimeters in diameter, tend to close prematurely in older adults, which can cause the over-inflated appearance on a chest X-ray that sometimes gets mistaken for disease.
Modeling studies have confirmed that both the redistribution of collagen and elastin away from the alveolar ducts and the resulting air-space enlargement contribute to the decline in recoil pressure.24PubMed. Evidence for age-dependent air-space enlargement contributing to loss of lung tissue elastic recoil pressure and increased shear modulus in older age Practically, this means that a seventy-year-old with perfectly healthy lungs will still have measurably less lung function than they did at twenty-five. The decline is gradual enough that most people never notice it in daily life, but it does reduce the physiological reserve available when the body is stressed, such as during a severe infection or surgery.
Biologic Therapies for Severe Asthma
For the minority of asthma patients whose disease is severe and does not respond well to standard inhalers and oral steroids, the past two decades have brought a wave of targeted biologic therapies. Seven monoclonal antibodies are now approved, each aimed at a different part of the inflammatory chain that drives severe asthma.25PubMed Central. Current and Emerging Biologic Therapies for Severe Asthma Some block the antibody IgE, which drives allergic asthma. Others target interleukin-5 or its receptor, cutting the signal that recruits eosinophils, a type of white blood cell central to many asthma flare-ups. Still others block interleukin-4 signaling or a molecule called TSLP that sits further upstream in the inflammatory pathway.
These therapies have shown meaningful reductions in flare-up rates and in the need for daily oral corticosteroids, along with improvements in lung function.26Breathe. A pragmatic guide to choosing biologic therapies in severe asthma The challenge for clinicians is matching the right drug to the right patient, since each biologic works best in a specific inflammatory profile. Blood eosinophil counts, IgE levels, and other biomarkers guide the choice, but there is no single test that definitively predicts who will respond best to which therapy. Some patients cycle through more than one biologic before finding the one that controls their disease.
High-Altitude Adaptation and Pulmonary Differences Across Populations
Populations that have lived at high altitude for thousands of years offer a natural experiment in pulmonary adaptation. Andean highlanders, Tibetans, and Ethiopian highlanders have each evolved distinct strategies for coping with chronically low oxygen levels, and those strategies show up most clearly in the lungs and circulation.
Andeans tend to have somewhat larger lung volumes and narrower gaps between the oxygen levels in alveolar air and arterial blood, suggesting more efficient gas transfer. They also show a slightly blunted vasoconstrictor response to low oxygen, meaning their pulmonary blood vessels do not squeeze down as aggressively at altitude.27PubMed Central. Human Genetic Adaptation to High Altitude: Evidence from the Andes However, they still experience elevated pulmonary artery pressure and some degree of right heart thickening, a trade-off that Tibetan highlanders have largely avoided. Tibetans instead show a stronger ventilatory response to low oxygen, better pulmonary diffusion capacity, greater muscle capillary density, and enhanced tissue blood flow, which together allow them to maintain near-normal cardiac function at altitude. Ethiopian highlanders, by contrast, maintain ventilatory patterns close to those of sea-level residents and show limited blood vessel reactivity to low oxygen, an approach that is the least studied of the three.28PubMed Central. Human adaptation to high-altitude: A contemporary comparison of the oxygen cascade in Andean, Tibetan and Ethiopian highlanders
These differences are not just academic curiosities. They underscore the point that there is more than one way to build a functional pulmonary system under stress, and they offer researchers clues about which aspects of oxygen transport can be modified, whether by evolution or potentially by medicine.
Sleep, Breathing, and the Upper Airway
Obstructive sleep apnea (OSA) sits at the intersection of pulmonary physiology and anatomy. For years, it was thought of primarily as a plumbing problem: the airway was too narrow, often due to jaw structure, and it collapsed during sleep. That picture has expanded considerably. The central nervous system’s regulation of breathing is now recognized as a major contributor to OSA. Ventilatory control, specifically how the brain responds to rising COâ‚‚ and falling oxygen during sleep, can destabilize breathing and cause the repeated cycles of airway collapse and arousal that define the disorder.29PubMed. Biomechanics of the upper airway: Changing concepts in the pathogenesis of obstructive sleep apnea This matters clinically because some patients who have surgery to advance the jaw, one of the most aggressive anatomical fixes for OSA, still have residual disease. Their anatomy has been corrected, but their breathing control has not.
The connection between sleep apnea and the pulmonary system runs deeper than airway obstruction. Repeated nighttime drops in blood oxygen trigger the same hypoxic pulmonary vasoconstriction discussed earlier, but in a cyclic, intermittent pattern. Over years, this can contribute to pulmonary hypertension, right heart strain, and systemic cardiovascular problems. The disorder is a reminder that the pulmonary system does not operate in isolation: it is wired into neural control, vascular regulation, and the mechanics of the upper airway all at once.
The Evolutionary Origins of Paired Lungs
Lungs did not arrive fully formed. Evolutionary studies tracing lung structure across vertebrates suggest that the ancestral lung was a single, unpaired organ. The transition to paired lungs happened in the lineage leading to land-dwelling animals, and it was a critical adaptation: having two lungs increased both the surface area available for gas exchange and the overall compliance of the respiratory system, making it easier to ventilate with air rather than water.30PubMed Central. Lung evolution in vertebrates and the water-to-land transition The water-to-land transition demanded a respiratory organ that could absorb oxygen efficiently from a medium roughly 800 times less dense than water, and paired lungs provided the volume and flexibility to meet that challenge. Modern lungfish still carry a transitional version of this anatomy, hinting at what the intermediate steps looked like hundreds of millions of years ago.